| |
| HCV |Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| Abstract Details |
 |
|
| |
| |
| |
|
|
| |
The persistence of underreporting of hepatitis C as an underlying or contributing cause of death, 2011-2017 |
|
|
|
|
| |
Clin Infect Dis. 2021 Feb 9;ciab108. doi: 10.1093/cid/ciab108. Online ahead of print.
Philip R Spradling 1, Yuna Zhong 1, Anne C Moorman 1, Loralee B Rupp 2, Mei Lu 2, Eyasu H Teshale 1, Mark A Schmidt 3, Yihe G Daida 4, Joseph A Boscarino 5, Stuart C Gordon 2 6
|
| |
|
|
| |
Author information
- 1Division of Viral Hepatitis, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
- 2Henry Ford Health System, Detroit, MI, USA.
- 3The Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
- 4The Center for Integrated Health Research, Kaiser Permanente Hawaii, Honolulu, HI, USA.
- 5Department of Population Health Sciences, Geisinger Clinic, Danville, PA, USA.
- 6Wayne State University School of Medicine, Detroit, MI, USA.
Abstract
Using electronic health records, we found that hepatitis C reporting on death certificates of 2,901 HCV-infected decedents from four U.S. healthcare organizations during 2011-2017 was documented in only 50% of decedents with hepatocellular carcinoma and less than half with decompensated cirrhosis. National figures likely underestimate the U.S. HCV mortality burden.
|
|
|
|
| |
| |
|
| |
|
|
|
|
|
